Oncogenic signaling pathways activated by RON receptor tyrosine kinase

Alla Danilkovitch-Miagkova1

  • 1Department of Immunochemistry, PPD Development, 2244 Dabney Road, Richmond, VA 23230, USA. Alla.Danilkovitch@richmond.ppdi.com

Insights

The RON receptor tyrosine kinase and its ligand MSP regulate normal cell functions. Aberrant RON signaling is implicated in cancer development and metastasis through activation of key oncogenic pathways.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The MET receptor tyrosine kinase family includes RON, expressed in macrophages, epithelial, and hematopoietic cells.
  • Macrophage stimulating protein (MSP) is the ligand for RON, regulating cell growth, survival, adhesion, motility, cytokine production, and phagocytosis.
  • RON plays a role in normal cellular functions and is increasingly recognized for its involvement in cancer.

Purpose of the Study:

  • To review the signaling pathways activated by RON.
  • To elucidate the role of RON in oncogenic cell transformation and tumor progression.
  • To highlight the potential involvement of RON in tumor metastasis.

Main Methods:

  • Literature review of accumulated data on RON function and signaling.
  • Analysis of experimental evidence linking RON mutations to oncogenic transformation.
  • Examination of RON expression and activity in primary tumors and cell lines.

Main Results:

  • RON is overexpressed and constitutively active in certain tumors and cell lines.
  • Experimental mutations in RON lead to oncogenic cell transformation.
  • RON activation is linked to susceptibility to virus-induced erythroleukemia in mice.
  • Constitutive activation of pathways like PI-3K/AKT, beta-catenin, MAPK, and JNK underlies RON-mediated transformation.

Conclusions:

  • RON-activated signaling pathways are crucial for normal cellular processes.
  • Dysregulated RON signaling contributes significantly to cancer development and progression.
  • Understanding RON pathways offers potential therapeutic targets for cancer treatment and metastasis inhibition.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...